Holen Sie sich die Stockscreener-App
172.57
3.32%
-5.93
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt THC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$178.50
Offen:
$179.57
24-Stunden-Volumen:
2.60M
Relative Volume:
1.84
Marktkapitalisierung:
$14.86B
Einnahmen:
$21.46B
Nettoeinkommen (Verlust:
$2.65B
KGV:
8.9734
EPS:
19.2312
Netto-Cashflow:
$3.35B
1W Leistung:
-0.35%
1M Leistung:
-10.33%
6M Leistung:
-11.22%
1J Leistung:
+2.98%
1-Tages-Spanne:
$171.45
$181.11
1-Wochen-Bereich:
$171.45
$184.85
52-Wochen-Spanne:
$146.60
$247.21
Tenet Healthcare Corp Stock (THC) Company Profile
Firmenname
Tenet Healthcare Corp
Sektor
Branche
Telefon
469-893-2200
Adresse
14201 DALLAS PARKWAY, DALLAS, TX
Compare THC vs HCA, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
THC
Tenet Healthcare Corp
|
172.57 | 14.86B | 21.46B | 2.65B | 3.35B | 19.23 |
HCA
Hca Healthcare Inc
|
375.17 | 83.23B | 76.39B | 7.81B | 7.93B | 29.08 |
DVA
Davita Inc
|
207.91 | 13.34B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
23.59 | 12.67B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
98.03 | 9.72B | 6.07B | 793.80M | 464.40M | 5.9914 |
Tenet Healthcare Corp Stock (THC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-05-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-26 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-02-26 | Eingeleitet | TD Cowen | Buy |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-16 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-11-22 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Eingeleitet | JP Morgan | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-03-29 | Eingeleitet | Wells Fargo | Overweight |
| 2022-02-10 | Hochstufung | UBS | Neutral → Buy |
| 2022-02-09 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-02-09 | Hochstufung | Truist | Hold → Buy |
| 2022-01-20 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-24 | Eingeleitet | UBS | Neutral |
| 2021-08-12 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-07-23 | Fortgesetzt | Citigroup | Buy |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-03 | Fortgesetzt | Goldman | Buy |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2021-01-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-12-15 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-11 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-26 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-12-09 | Hochstufung | UBS | Neutral → Buy |
| 2019-11-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-08-14 | Fortgesetzt | Goldman | Neutral |
| 2019-02-26 | Bestätigt | BofA/Merrill | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Equal-Weight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
| 2018-12-17 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-06-29 | Herabstufung | Jefferies | Buy → Hold |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-30 | Fortgesetzt | Wells Fargo | Market Perform |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-19 | Bestätigt | Mizuho | Neutral |
| 2017-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Tenet Healthcare Corp Aktie (THC) Neueste Nachrichten
Why Tenet’s My Health Rec quietly matters for everyday patients - AD HOC NEWS
Tenet Healthcare Corp (THC) Shares Fall 3.3% -- What GF Score of 80 Tells Investors - GuruFocus
HCA Healthcare Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Judge denies Leapfrog Group’s appeal of Tenet lawsuit ruling - Modern Healthcare News
Tenet (THC) Upgraded to Buy: Here's Why - Yahoo Finance Singapore
Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Tenet Healthcare Corp (THC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HCA Healthcare Inc. stock outperforms competitors despite losses on the day - MarketWatch
BofA Maintains Buy Rating on Tenet Healthcare (THC) - Insider Monkey
Tenet Healthcare Corp (THC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tenet Healthcare Corp (THC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HCA Healthcare Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Tenet Healthcare Corp (THC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tenet Healthcare (THC) Laps the Stock Market: Here's Why - Yahoo Finance
HCA Healthcare Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Why Tenet Healthcare (THC) is a top value stock for the long term - MSN
HCA Healthcare Inc. stock rises Thursday, still underperforms market - MarketWatch
Hospital Rating Group Calls $10.5M Fee Bid 'Unreasonable' - Law360
THC Technical Analysis & Stock Price Forecast - Intellectia AI
HCA Healthcare Inc. stock underperforms Monday when compared to competitors - MarketWatch
Did Moody’s Credit Upgrade Just Reframe Tenet Healthcare’s (THC) Deleveraging Story for Investors? - Yahoo Finance
Jefferies recaps meetings with Healthcare Services companies - Investing.com
ETFs Investing in Tenet Healthcare Corporation Stocks - TradingView
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
Tenet Healthcare (THC) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Moody’s upgrades Tenet Healthcare rating on deleveraging By Investing.com - Investing.com Canada
Moody’s upgrades Tenet Healthcare rating on deleveraging - Investing.com
Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
HCA Healthcare Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Is Tenet Healthcare Corp (THC) a Bargain After 3.8% Drop? GF Val - GuruFocus
Is Tenet Healthcare Corp (THC) a Bargain After 3.8% Drop? GF Value Says Undervalued - GuruFocus
Tenet Healthcare Corp (THC) Stock Price, Trades & News - GuruFocus
Tenet Healthcare Corp stock (US88033G4073): shares at fresh 20-day low as investors reassess hospita - AD HOC NEWS
Encompass Health to Expand WV Footprint With 36-Bed Bridgeport Unit - Yahoo Finance
Tenet Healthcare Corp (THC) Stock Analysis: A 39.5% Upside Potential Amidst Robust Analyst Ratings - DirectorsTalk Interviews
Insider Selling Alert: J Kerrey Sells Shares of Tenet Healthcare Corp (THC) - GuruFocus
Tenet Healthcare Q1 2026 Earnings: Strong EPS Beat Fuels Positive Stock ReactionEarnings Surprise Score - newsline.com
Tenet Healthcare director J. Robert Kerrey sells $983,920 stock By Investing.com - Investing.com Australia
Tenet Healthcare director J. Robert Kerrey sells $983,920 stock - Investing.com
Tenet Healthcare (THC) director sells 5,638 shares, retains 16,804 - Stock Titan
Tenet Healthcare (THC) shareholders back board, pay plan and auditor at 2026 meeting - Stock Titan
Insider Sell: Nadja West Sells 3,000 Shares of Tenet Healthcare Corp (THC) - GuruFocus
Tenet Healthcare (THC) director awarded 1,188 restricted stock units as equity pay - Stock Titan
Tenet Healthcare (NYSE: THC) director awarded 1,188 restricted stock units - Stock Titan
Tenet Healthcare (THC) director receives 1,188 RSUs equity grant - Stock Titan
Tenet Healthcare Corp (THC) Shares Fall 4.3% -- What GF Score of 80 Tells Investors - GuruFocus
Fidelity submits Form 144 for THC restricted shares (NYSE: THC) - Stock Titan
[144] TENET HEALTHCARE CORP SEC Filing - Stock Titan
Tenet (NYSE: THC) director settles RSUs, returns shares to company - Stock Titan
Tenet Healthcare (THC) director converts 1,333 RSUs, boosting holdings to 4,446 shares - Stock Titan
Tenet Healthcare (THC) director exercises 1,333 RSUs into common shares, now holding 36,604 - Stock Titan
Finanzdaten der Tenet Healthcare Corp-Aktie (THC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.27%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):